Status:

COMPLETED

Metabolically Normal and Metabolically Abnormal Obesity

Lead Sponsor:

Washington University School of Medicine

Conditions:

Obesity

Metabolic Syndrome

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The purpose of this study is to learn more about why some obese persons are resistant to developing obesity-related metabolic diseases (such as diabetes and cardiovascular disease), while others are p...

Eligibility Criteria

Inclusion

  • Obese subjects (BMI 30.0 - 39.9 kg/m2)
  • Sedentary subjects (exercise less than 1 hr/wk)

Exclusion

  • Pregnant or lactating women
  • Michigan Alcohol Screening Test score ≥4
  • Active or previous history of liver disease
  • Active or previous history of diabetes
  • history of alcohol abuse, or currently consuming ≥20 g alcohol/day
  • Severe hypertriglyceridemia (\>300 mg/dL)
  • Smoke tobacco
  • Take medication that might confound the study results

Key Trial Info

Start Date :

August 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2015

Estimated Enrollment :

71 Patients enrolled

Trial Details

Trial ID

NCT01184170

Start Date

August 1 2010

End Date

February 1 2015

Last Update

July 2 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Metabolically Normal and Metabolically Abnormal Obesity | DecenTrialz